Advertisement

Index by author

February 01, 1985; Volume 232,Issue 2

  1. Pals, D T

    1. Cardiovascular effects of losulazine hydrochloride, a peripheral norepinephrine-depleting agent, in nonhuman primates.
      D T Pals and G L DeGraaf
      Journal of Pharmacology and Experimental Therapeutics February 1985, 232 (2) 407-412;

  2. Parker, E M

    1. Evidence for autoreceptor modulation of endogenous dopamine release from rabbit caudate nucleus in vitro.
      E M Parker and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics February 1985, 232 (2) 492-500;

  3. Pfeiffer, N

    1. Presynaptic opioid receptor subtypes in the rabbit ear artery.
      P Illes, N Pfeiffer, I von Kügelgen and K Starke
      Journal of Pharmacology and Experimental Therapeutics February 1985, 232 (2) 526-533;

  4. Pieroni, J P

    1. Deficiency in 15-hydroxyprostaglandin dehydrogenase activity after unilateral ureteral obstruction of the dog kidney.
      P Y Wong, J P Pieroni, P H Chao, D Sarubbi, D N Marion, C T Albanase and E D Vaughan
      Journal of Pharmacology and Experimental Therapeutics February 1985, 232 (2) 470-474;

  5. Rastogi, S K

    1. Effects of drugs on schedule-controlled behavior in rats during chronic haloperidol administration.
      S K Rastogi and D E McMillan
      Journal of Pharmacology and Experimental Therapeutics February 1985, 232 (2) 295-300;

  6. Saeki, K

    1. delta 9-Tetrahydrocannabinol decreases turnover of brain histamine.
      R Oishi, Y Itoh, M Nishibori and K Saeki
      Journal of Pharmacology and Experimental Therapeutics February 1985, 232 (2) 513-518;

  7. Saito, K

    1. Pantoyl-gamma-aminobutyric acid facilitates cholinergic function in the central nervous system.
      M Nakahiro, N Fujita, I Fukuchi, K Saito, T Nishimura and H Yoshida
      Journal of Pharmacology and Experimental Therapeutics February 1985, 232 (2) 501-506;

  8. Sanders, V M

    1. Role of alpha adrenoceptor activation in modulating the murine primary antibody response in vitro.
      V M Sanders and A E Munson
      Journal of Pharmacology and Experimental Therapeutics February 1985, 232 (2) 395-400;

  9. Sarubbi, D

    1. Deficiency in 15-hydroxyprostaglandin dehydrogenase activity after unilateral ureteral obstruction of the dog kidney.
      P Y Wong, J P Pieroni, P H Chao, D Sarubbi, D N Marion, C T Albanase and E D Vaughan
      Journal of Pharmacology and Experimental Therapeutics February 1985, 232 (2) 470-474;

  10. Satake, N

    1. Inhibitory effect of ouabain on the palytoxin-induced contraction of human umbilical artery.
      Y Ishida, N Satake, J Habon, H Kitano and S Shibata
      Journal of Pharmacology and Experimental Therapeutics February 1985, 232 (2) 557-560;
« Previous (Pages : 6 7 8 9 10 11 12 13 14 ... 14) Next »
Back to top

In this issue

Advertisement